Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Convergent generation of atypical prions in knockin mouse models of genetic prion disease
Surabhi Mehra, … , Walker S. Jackson, Joel C. Watts
Surabhi Mehra, … , Walker S. Jackson, Joel C. Watts
Published August 1, 2024
Citation Information: J Clin Invest. 2024;134(15):e176344. https://doi.org/10.1172/JCI176344.
View: Text | PDF
Research Article Neuroscience

Convergent generation of atypical prions in knockin mouse models of genetic prion disease

  • Text
  • PDF
Abstract

Most cases of human prion disease arise due to spontaneous misfolding of WT or mutant prion protein, yet recapitulating this event in animal models has proven challenging. It remains unclear whether spontaneous prion generation can occur within the mouse lifespan in the absence of protein overexpression and how disease-causing mutations affect prion strain properties. To address these issues, we generated knockin mice that express the misfolding-prone bank vole prion protein (BVPrP). While mice expressing WT BVPrP (I109 variant) remained free from neurological disease, a subset of mice expressing BVPrP with mutations (D178N or E200K) causing genetic prion disease developed progressive neurological illness. Brains from spontaneously ill knockin mice contained prion disease–specific neuropathological changes as well as atypical protease-resistant BVPrP. Moreover, brain extracts from spontaneously ill D178N- or E200K-mutant BVPrP–knockin mice exhibited prion seeding activity and transmitted disease to mice expressing WT BVPrP. Surprisingly, the properties of the D178N- and E200K-mutant prions appeared identical before and after transmission, suggesting that both mutations guide the formation of a similar atypical prion strain. These findings imply that knockin mice expressing mutant BVPrP spontaneously develop a bona fide prion disease and that mutations causing prion diseases may share a uniform initial mechanism of action.

Authors

Surabhi Mehra, Matthew E.C. Bourkas, Lech Kaczmarczyk, Erica Stuart, Hamza Arshad, Jennifer K. Griffin, Kathy L. Frost, Daniel J. Walsh, Surachai Supattapone, Stephanie A. Booth, Walker S. Jackson, Joel C. Watts

×

Figure 1

Generation and characterization of knockin mice expressing WT or mutant bank vole PrP.

Options: View larger image (or click on image) Download as PowerPoint
Generation and characterization of knockin mice expressing WT or mutant ...
(A) Schematic of the gene-targeted alleles in knockin mice expressing either WT (kiBVIWT), E200K-mutant (kiBVIE200K), or D178N-mutant (kiBVID178N) BVPrP(I109). The 8 amino acid residue differences between the mature forms of bank vole and mouse PrP are shown, as are the approximate epitopes for the anti-PrP antibodies used in this study. (B) Immunoblots for PrP in brain extracts from 3 mice each for the indicated knockin lines. BVPrP was detected using the antibodies HuM-P and HuM-D18, and both blots were reprobed with an anti-actin antibody. (C) ELISA-based quantification of relative BVPrP levels (mean ± SD) in brain extracts from knockin mice (n = 3 per line). Statistical significance was assessed using Welch’s ANOVA followed by Dunnett’s T3 multiple-comparison test. (D) Immunoblots for PrP in brain extracts from the indicated mouse lines probed with antibodies that recognize both mouse and bank vole PrP (POM1) or only mouse PrP (HuM-R1). Both blots were reprobed with an antibody against actin. (E) Immunoblots for PrP in PNGase F–treated brain extracts from 3 mice each for the indicated knockin lines. BVPrP was detected using the antibodies HuM-P and HuM-D18. Full-length BVPrP as well as the C1 and C2 endoproteolytic products are indicated. In all panels, the molecular weight markers indicate kilodaltons.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts